Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lin, Qi ^a   Ye, Qinghai ^a   Zhu, Dexiang ^a   Wei, Ye ^a   Ren, Li ^a   Ye, Lechi ^a   Feng, Qingyang ^a   Xu, Pingping ^a   Zheng, Peng ^a   Lv, Minzhi ^a   Fan, Jia ^a   Xu, Jianmin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN; ANTINEOPLASTIC AGENT; BRAF PROTEIN, HUMAN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BRAF GENE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; ONCOGENE K RAS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; SURVIVAL RATE; TUMOR INVASION; TUMOR RECURRENCE; ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; GENETICS; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS; SECONDARY; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84929938798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105747     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Van Cutsem E, Rivera F, Berry S, Kretzschmar A, Michael M, et al. (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20: 1842-1847.
3. Yin Z, Liu C, Chen Y, Bai Y, Shang C, et al. (2013) Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? Hepatology 57: 2346-2357.
4. Mayo SC, Pulitano C, Marques H, Lamelas J, Wolfgang CL, et al. (2013) Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg 216: 707-716; discussion 716-708.
5. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, et al. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657; discussion 657-648.
6. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, et al. (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244: 254-259. (Pubitemid 44305540)
7. Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES (2009) Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer 115: 752-759.
8. Martin RC 2nd, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208: 842-850; discussion 850-842.
9. Slesser AA, Simillis C, Goldin R, Brown G, Mudan S, et al. (2013) A metaanalysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol 22: 36-47.
10. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, et al. (2007) Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246: 806-814. (Pubitemid 350035657)
11. de Santibanes E, Fernandez D, Vaccaro C, Quintana GO, Bonadeo F, et al. (2010) Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg 34: 2133-2140.
12. Xu JM, Qin XY, Wang JP, Zhang SZ, Zhong YS, et al. (2011) Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. Journal of Cancer Research and Clinical Oncology 137: 1379-1396.
13. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. (2009) TNM classification of malignant tumours. Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell.
14. Sebastian SO, Gonzalez JM, Paricio PP, Perez JS, Flores DP, et al. (2000) Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 135: 272-277. (Pubitemid 30154566)
15. Teramukai S, Ochiai K, Tada H, Fukushima M, Japan Multinational Trial Organization OC (2007) PIEPOC: a new prognostic index for advanced epithelial ovarian cancer-Japan Multinational Trial Organization OC01-01. J Clin Oncol 25: 3302-3306. (Pubitemid 47325616)
16. Francart J, Vaes E, Henrard S, Legrand C, Baas P, et al. (2009) A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials. Eur J Cancer 45: 2304-2311.
17. Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, et al. (1996) Reduced hepatic acute-phase response after simultaneous resection for gastrointestinal cancer with synchronous liver metastases. British Journal of Surgery 83: 1002-1006. (Pubitemid 26228229)
18. Abbott AM, Parsons HM, Tuttle TM, Jensen EH (2013) Short-Term Outcomes after Combined Colon and Liver Resection for Synchronous Colon Cancer Liver Metastases: A Population Study. Annals of Surgical Oncology 20: 139-147.
19. John SK, Robinson SM, Rehman S, Harrison B, Vallance A, et al. (2013) Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg 30: 293-301.
20. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
21. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135.
22. Settmacher U, Dittmar Y, Knosel T, Schone U, Heise M, et al. (2011) Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis 26: 967-981.
23. De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, et al. (2010) Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 11: 753-762.
24. Laurent-Puig P, Cayre A, Manceau G, Buc E, Bachet JB, et al. (2009) Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J Clin Oncol 27: 5924-5930.
25. Tol J, Nagtegaal ID, Punt CJ (2009) BRAF mutation in metastatic colorectal cancer. N Engl J Med 361: 98-99.
26. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016. (Pubitemid 351392040)
27. Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, et al. (2009) Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol 16: 1809-1819.
28. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, et al. (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7: 109-115; discussion 116-107.
29. Araujo R, Gonen M, Allen P, Blumgart L, DeMatteo R, et al. (2013) Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. Ann Surg Oncol 20: 4312-4321.
30. Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, et al. (2013) Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol 20: 295-304.